全球兒科疫苗市場規模:疫苗類型、用途、技術、區域預測(2022-2028)
市場調查報告書
商品編碼
1077566

全球兒科疫苗市場規模:疫苗類型、用途、技術、區域預測(2022-2028)

Global Pediatric Vaccines Market Size study, by Vaccine Type, by Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella, and Other Applications), by Technology and Regional Forecasts 2022-2028

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

到 2021 年,全球兒科疫苗市場將達到約 478 億美元,預計在 2022 年至 2028 年期間,將以超過 8.3% 的有利增長率增長。

預計兒科人口的增加將推動市場增長,而肺炎、哮喘和水痘等兒科疾病的高患病率也有望帶動整個市場。此外,疫苗研發的增加、政府對減輕疾病負擔的支持以及疫苗給藥途徑的開發預計將在預測期內增加市場增長。然而,在 2022 年至 2028 年的預測期內,偏遠地區難以獲得疫苗以及疫苗的高成本預計將阻礙市場增長。

本報告對全球兒科疫苗市場進行研究和分析,並提供市場趨勢、競爭狀況、按細分市場和地區劃分的市場分析以及主要公司概況等系統信息。

目錄

第 1 章執行摘要

第二章全球兒科疫苗市場的定義和範圍

第三章全球兒童疫苗市場動態

  • 兒科疫苗市場影響分析(2020-2028)

第四章全球兒童疫苗市場行業分析

  • 波特五力模型
  • PEST 分析
  • 投資採用模式
  • 分析師建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估:COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 前後的市場情景

第 6 章全球兒童疫苗市場:按疫苗類型

  • 市場快照
  • 市場表現/潛力分析:按疫苗類型
  • 市場估計和預測:按疫苗類型(2018-2028 年)
  • 細分分析
    • 一價
    • 多值

第 7 章全球兒童疫苗市場:按用途

  • 市場快照
  • 市場表現/潛力分析:按應用
  • 市場估計和預測:按應用分類 (2018-2028)
  • 細分分析
    • 肺炎球菌感染
    • 流感
    • 麻疹、腮腺炎、風疹 (MMR)
    • 其他用途

第 8 章全球兒童疫苗市場:按技術分類

  • 市場快照
  • 市場表現/潛力分析:按技術
  • 市場估計和預測:按技術(2018-2028 年)
  • 細分分析
    • 弱學生
    • 不活動
    • 類毒素
    • 組合型
    • 其他技術

第 9 章全球兒童疫苗市場:區域分析

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 其他領域

第10章衝突信息

  • 主要市場策略
  • 公司簡介
    • GlaxoSmithKline Plc.
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi S.A.
    • Panacea Biotec
    • Zydus Cadila
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Indian Immunologicals Ltd.

第11章 調查流程

Global Pediatric Vaccines Market is valued at approximately USD 47.8 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2028. Pediatric Vaccines trigger the body's immune system to produce the requisite antibodies to protect infants from various diseases such as polio, pneumonia, and influenza. These vaccines are necessary to develop resistance to infections caused by these pathogens. An increase in the pediatric population is driving the market growth. For instance, according to the World Bank, the birth rate, (per 1,000 people) increased from 17.888 in 2019 to 17.982 in 2020. Furthermore, the total market is also expected to be driven by the high prevalence of pediatric diseases such as pneumonia, asthma, chickenpox, and others. According to the World Health Organization, in 2019, pneumonia causes 14% of all deaths of children under 5 years old, killing 740 180 children. Also, increasing R&D in vaccines, government support to reduce burden of diseases, and developments in the route of vaccine administration are likely to increase the market growth during the forecast period. However, low accessibility of vaccines to remote areas and high cost of vaccines impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Pediatric Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to the well-established healthcare infrastructure and wide commercial availability of vaccines. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 due to favorable government initiatives regarding vaccine development and awareness and increasing number of diseases.

Major market players included in this report are:

GlaxoSmithKline Plc.

Merck & Co., Inc.

Pfizer Inc.

Sanofi S.A.

Panacea Biotec

Zydus Cadila

Emergent BioSolutions Inc.

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Indian Immunologicals Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Vaccine Type:

Monovalent

Multivalent

By Application:

Pneumococcal Disease

Influenza

Measles, Mumps and Rubella (MMR)

Other Applications

By Technology:

Live Attenuated

Inactivated

Toxoid

Conjugate

Other Technologies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Pediatric Vaccines Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Pediatric Vaccines Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Pediatric Vaccines Market, by Vaccine Type, 2020-2028 (USD Billion)
    • 1.2.3. Pediatric Vaccines Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Pediatric Vaccines Market, by Technology, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pediatric Vaccines Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pediatric Vaccines Market Dynamics

  • 3.1. Pediatric Vaccines Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing pediatric population
      • 3.1.1.2. High prevalence of pediatric diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low accessibility of vaccines to remote areas
      • 3.1.2.2. High cost of vaccines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D in vaccines
      • 3.1.3.2. Developments in the route of vaccine administration

Chapter 4. Global Pediatric Vaccines Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Pediatric Vaccines Market, by Vaccine Type

  • 6.1. Market Snapshot
  • 6.2. Global Pediatric Vaccines Market by Vaccine Type, Performance - Potential Analysis
  • 6.3. Global Pediatric Vaccines Market Estimates & Forecasts by Vaccine Type, 2018-2028 (USD Billion)
  • 6.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 6.4.1. Monovalent
    • 6.4.2. Multivalent

Chapter 7. Global Pediatric Vaccines Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Pediatric Vaccines Market by Application, Performance - Potential Analysis
  • 7.3. Global Pediatric Vaccines Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 7.4.1. Pneumococcal Disease
    • 7.4.2. Influenza
    • 7.4.3. Measles, Mumps and Rubella (MMR)
    • 7.4.4. Other Applications

Chapter 8. Global Pediatric Vaccines Market, by Technology

  • 8.1. Market Snapshot
  • 8.2. Global Pediatric Vaccines Market by Technology, Performance - Potential Analysis
  • 8.3. Global Pediatric Vaccines Market Estimates & Forecasts by Technology, 2018-2028 (USD Billion)
  • 8.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 8.4.1. Live Attenuated
    • 8.4.2. Inactivated
    • 8.4.3. Toxoid
    • 8.4.4. Conjugate
    • 8.4.5. Other Technologies

Chapter 9. Global Pediatric Vaccines Market, Regional Analysis

  • 9.1. Pediatric Vaccines Market, Regional Market Snapshot
  • 9.2. North America Pediatric Vaccines Market
    • 9.2.1. U.S. Pediatric Vaccines Market
      • 9.2.1.1. Vaccine Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Technology breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Pediatric Vaccines Market
  • 9.3. Europe Pediatric Vaccines Market Snapshot
    • 9.3.1. U.K. Pediatric Vaccines Market
    • 9.3.2. Germany Pediatric Vaccines Market
    • 9.3.3. France Pediatric Vaccines Market
    • 9.3.4. Spain Pediatric Vaccines Market
    • 9.3.5. Italy Pediatric Vaccines Market
    • 9.3.6. Rest of Europe Pediatric Vaccines Market
  • 9.4. Asia-Pacific Pediatric Vaccines Market Snapshot
    • 9.4.1. China Pediatric Vaccines Market
    • 9.4.2. India Pediatric Vaccines Market
    • 9.4.3. Japan Pediatric Vaccines Market
    • 9.4.4. Australia Pediatric Vaccines Market
    • 9.4.5. South Korea Pediatric Vaccines Market
    • 9.4.6. Rest of Asia Pacific Pediatric Vaccines Market
  • 9.5. Latin America Pediatric Vaccines Market Snapshot
    • 9.5.1. Brazil Pediatric Vaccines Market
    • 9.5.2. Mexico Pediatric Vaccines Market
  • 9.6. Rest of The World Pediatric Vaccines Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. GlaxoSmithKline Plc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Merck & Co., Inc.
    • 10.2.3. Pfizer Inc.
    • 10.2.4. Sanofi S.A.
    • 10.2.5. Panacea Biotec
    • 10.2.6. Zydus Cadila
    • 10.2.7. Emergent BioSolutions Inc.
    • 10.2.8. Serum Institute of India Pvt. Ltd.
    • 10.2.9. Bharat Biotech
    • 10.2.10. Indian Immunologicals Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pediatric Vaccines Market, report scope
  • TABLE 2. Global Pediatric Vaccines Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Pediatric Vaccines Market estimates & forecasts by Vaccine Type 2018-2028 (USD Billion)
  • TABLE 4. Global Pediatric Vaccines Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Pediatric Vaccines Market estimates & forecasts by Technology 2018-2028 (USD Billion)
  • TABLE 6. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Pediatric Vaccines Market
  • TABLE 56. List of primary sources, used in the study of global Pediatric Vaccines Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Pediatric Vaccines Market, research methodology
  • FIG 2. Global Pediatric Vaccines Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Pediatric Vaccines Market, key trends 2021
  • FIG 5. Global Pediatric Vaccines Market, growth prospects 2022-2028
  • FIG 6. Global Pediatric Vaccines Market, porters 5 force model
  • FIG 7. Global Pediatric Vaccines Market, pest analysis
  • FIG 8. Global Pediatric Vaccines Market, value chain analysis
  • FIG 9. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Pediatric Vaccines Market, regional snapshot 2018 & 2028
  • FIG 15. North America Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Pediatric Vaccines Market, company market share analysis (2021)